The Community Guide

- gsearch

Search Results

All Collections

Morbidity and Mortality Weekly Report (MMWR)

The Morbidity and Mortality Weekly Report (MMWR) series are CDC’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. The MMWR series includes the following publications: MMWR Weekly, MMWR Recommendations and Reports, CDC Surveillance Summaries and MMWR Supplements. These journals are freely available to the public as Diamond Open Access. For more on MMWR, visit https://www.cdc.gov/mmwr/index.html.

Narrow Results:

Weekly Report: Morbidity and Mortality Weekly Report (MMWR) 16

2022 12
2021 2
2020 2

Journal Article 16

Guidance 1

1 - 16 of 16 Results

Refine Results

Refine Results:

Characteristics Associated with Hospitalization Among Patients with COVID-19 —metropolitan Atlanta, Georgia, March–April 2020

CITE Title : Characteristics Associated with Hospitalization Among Patients with COVID-19 —metropolitan Atlanta, Georgia, March–April 2020 Personal Author(s) : Killerby, Marie E.;Link-Gelles, Ruth;Haight, Sarah C.;Schrodt, Caroline A.;England, Lucinda;Gomes, Danica J.;Shamout, Mays;Pettrone, Kristen;O’Laughlin, Kevin;Kimball, Anne;Blau, Erin F.;Burnett, Eleanor;Ladva, Chandresh N.;Szablewski, Christine M.;Tobin-D’Angelo, Melissa;Oosmanally, Nadine;Drenzek, Cherie;Murphy, David J.;Blum, James M.;Hollberg, Julie;Lefkove, Benjamin;Brown, Frank W.;Shimabukuro, Tom;Midgley, Claire M.;Tate, Jacqueline E.; Corporate Authors(s) : CDC COVID-19 Response Clinical Team.;CDC COVID-19 Emergency Response Team.;Centers for Disease Control and Prevention (U.S.), Epidemic Intelligence Service.;Georgia. Department of Public Health.;Emory University School of Medicine.;Emory Decatur Hospital.; Published Date : June 17, 2020 Pages in Document : 5 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2020; v. 69 Early Release URL : https://stacks.cdc.gov/view/cdc/89420 Killerby, Marie E. et al. (2020). Characteristics Associated with Hospitalization Among Patients with COVID-19 —metropolitan Atlanta, Georgia, March–April 2020. 69 Killerby, Marie E. et al. "Characteristics Associated with Hospitalization Among Patients with COVID-19 —metropolitan Atlanta, Georgia, March–April 2020" 69 (2020) Killerby, Marie E. et al. "Characteristics Associated with Hospitalization Among Patients with COVID-19 —metropolitan Atlanta, Georgia, March–April 2020" vol. 69, 2020 Export RIS Citation Information.

:

Killerby, Marie E. ;

Link-Gelles, Ruth

June 17, 2020 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic?: Hospitalized COVID-19 patients are more commonly older, male, of black race, and have underlying conditions. ...
Risk for In-hospital Complications Associated with COVID-19 and Influenza — Veterans Health Administration, United States, October 1, 2018–May 31, 2020

CITE Title : Risk for In-hospital Complications Associated with COVID-19 and Influenza — Veterans Health Administration, United States, October 1, 2018–May 31, 2020 Personal Author(s) : Cates, Jordan;Lucero-Obusan, Cynthia;Dahl, Rebecca M.;Schirmer, Patricia;Garg, Shikha;Oda, Gina;Hall, Aron J.;Langley, Gayle;Havers, Fiona P.;Holodniy, Mark;Cardemil, Cristina V.; Corporate Authors(s) : CDC COVID-19 Emergency Response Team.;Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service.;United States Veterans Administration. Office of Population Health. Public Health Surveillance and Research Group.;United States Public Health Service.;Stanford University. School of Medicine. Division of Infectious Diseases & Geographic Medicine.; Published Date : October 20, 2020 Pages in Document : 7 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2020; v. 69 Early Release URL : https://stacks.cdc.gov/view/cdc/95595 Cates, Jordan et al. (2020). Risk for In-hospital Complications Associated with COVID-19 and Influenza — Veterans Health Administration, United States, October 1, 2018–May 31, 2020. 69 Cates, Jordan et al. "Risk for In-hospital Complications Associated with COVID-19 and Influenza — Veterans Health Administration, United States, October 1, 2018–May 31, 2020" 69 (2020) Cates, Jordan et al. "Risk for In-hospital Complications Associated with COVID-19 and Influenza — Veterans Health Administration, United States, October 1, 2018–May 31, 2020" vol. 69, 2020 Export RIS Citation Information.

:

Cates, Jordan ;

Lucero-Obusan, Cynthia

October 20, 2020 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Patients hospitalized with COVID-19 are reported to be at risk for respiratory and nonrespiratory Complication...
Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021

CITE Title : Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021 Personal Author(s) : Brooks, John T.;Beezhold, Donald H.;Noti, John D.;Coyle, Jayme P.;Derk, Raymond C.;Blachere, Francoise M.;Lindsley, William G.;Singleton, James A.; Corporate Authors(s) : CDC COVID-19 Emergency Response Team.;National Institute for Occupational Safety and Health. Health Effects Laboratory Division.; Published Date : February 10, 2021 Pages in Document : 4 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2021; v. 70 Early Release URL : https://stacks.cdc.gov/view/cdc/102366 Brooks, John T. et al. (2021). Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021. 70 Brooks, John T. et al. "Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021" 70 (2021) Brooks, John T. et al. "Maximizing Fit for Cloth and Medical Procedure Masks to Improve Performance and Reduce SARS-CoV-2 Transmission and Exposure, 2021" vol. 70, 2021 Export RIS Citation Information.

:

Brooks, John T. ;

Beezhold, Donald H.

February 10, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Universal masking is recommended to slow the spread of COVID-19. Cloth masks and medical procedure masks subst...
Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021

CITE Title : Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021 Personal Author(s) : Britton, Amadea;Slifka, Kara M. Jacobs;Edens, Chris;Nanduri, Srinivas Acharya;Bart, Stephen M.;Shang, Nong;Harizaj, Adora;Armstrong, Jillian;Xu, Kerui;Ehrlich, Hanna Y.;Soda, Elizabeth;Derado, Gordana;Verani, Jennifer R.;Schrag, Stephanie J.;Jernigan, John A.;Leung, Vivian H.;Parikh, Sunil; Corporate Authors(s) : CDC COVID-19 Emergency Response Team.;Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service.;Connecticut Department of Public Health.;Yale School of Public Health.; Published Date : March 15, 2021 Pages in Document : 7 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2021; v. 70 Early Release URL : https://stacks.cdc.gov/view/cdc/104146 Britton, Amadea et al. (2021). Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021. 70 Britton, Amadea et al. "Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021" 70 (2021) Britton, Amadea et al. "Effectiveness of the Pfizer-BioNTech COVID-19 Vaccine Among Residents of Two Skilled Nursing Facilities Experiencing COVID-19 Outbreaks — Connecticut, December 2020–February 2021" vol. 70, 2021 Export RIS Citation Information.

:

Britton, Amadea ;

Slifka, Kara M. Jacobs

March 15, 2021 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Skilled nursing facility (SNF) residents, generally older and with more underlying medical conditions than com...
Cardiac Complications After SARS-CoV-2 Infection and MRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022

CITE Title : Cardiac Complications After SARS-CoV-2 Infection and MRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022 Personal Author(s) : Block, Jason P.;Boehmer, Tegan K.;Forrest, Christopher B.;Carton, Thomas W.;Lee, Grace M.;Ajani, Umed A.;Christakis, Dimitri A.;Cowell, Lindsay G.;Draper, Christine;Ghildayal, Nidhi;Harris, Aaron M.;Kappelman, Michael D.;Ko, Jean Y.;Mayer, Kenneth H.;Nagavedu, Kshema;Oster, Matthew E.;Paranjape, Anuradha;Puro, Jon;Ritchey, Matthew D.;Shay, David K.;Thacker, Deepika;Gundlapalli, Adi V.; Corporate Authors(s) : Harvard Pilgrim Health Care Institute. Department of Population Medicine.;CDC COVID-19 Emergency Response Team.;Children’s Hospital of Philadelphia. Applied Clinical Research Center. Department of Pediatrics.;Louisiana Public Health Institute.;Stanford University School of Medicine. Department of Pediatrics.;Center for Child Health, Behavior and Development, Seattle Children’s Research Institute, Seattle Children’s Hospital, Seattle, Washington;University of Texas Southwestern Medical Center at Dallas. Department of Population and Data Sciences and Department of Immunology.;University of North Carolina at Chapel Hill. School of Medicine. Center for Gastrointestinal Biology and Disease.;Fenway Institute.;Children’s Healthcare of Atlanta.;Lewis Katz School of Medicine. Department of Medicine.;OCHIN, Inc.;Nemours Children’s Health System. Nemours Cardiac Center.;National Patient-Centered Clinical Research Network.; Published Date : April 1, 2022 Pages in Document : 7 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2022; v. 71 Early Release URL : https://stacks.cdc.gov/view/cdc/115913 Block, Jason P. et al. (2022). Cardiac Complications After SARS-CoV-2 Infection and MRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022. 71 Block, Jason P. et al. "Cardiac Complications After SARS-CoV-2 Infection and MRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022" 71 (2022) Block, Jason P. et al. "Cardiac Complications After SARS-CoV-2 Infection and MRNA COVID-19 Vaccination — PCORnet, United States, January 2021–January 2022" vol. 71, 2022 Export RIS Citation Information.

:

Block, Jason P. ;

Boehmer, Tegan K.

April 1, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Studies have found an increased risk for cardiac Complications after SARS-CoV-2 infection and mRNA COVID-19 va...
Ventilation Improvement Strategies Among K–12 Public Schools — the National School COVID-19 Prevention Study, United States, February 14–March 27, 2022

CITE Title : Ventilation Improvement Strategies Among K–12 Public Schools — the National School COVID-19 Prevention Study, United States, February 14–March 27, 2022 Personal Author(s) : Pampati, Sanjana;Rasberry, Catherine N.;McConnell, Luke;Timpe, Zach;Lee, Sarah;Spencer, Patricia;Moore, Shamia;Mead, Kenneth R.;Murray, Colleen Crittenden;Deng, Xiaoyi;Iachan, Ronaldo;Tripathi, Tasneem;Martin, Stephen B.;Barrios, Lisa C.; Corporate Authors(s) : National Center for HIV, Viral Hepatitis, STD, and TB Prevention (U.S.)Division of Adolescent and School Health.;CDC COVID-19 Emergency Response Team.;ICF.;National Center for Chronic Disease Prevention and Health Promotion (U.S.)Division of Population Health.;Oak Ridge Institute for Science and Education.;National Institute for Occupational Safety and Health. Division of Field Studies and Engineering.;National Institute for Occupational Safety and Health. Respiratory Health Division.; Published Date : June 7, 2022 Pages in Document : 6 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2022; v. 71 Early Release URL : https://stacks.cdc.gov/view/cdc/118074 Pampati, Sanjana et al. (2022). Ventilation Improvement Strategies Among K–12 Public Schools — the National School COVID-19 Prevention Study, United States, February 14–March 27, 2022. 71 Pampati, Sanjana et al. "Ventilation Improvement Strategies Among K–12 Public Schools — the National School COVID-19 Prevention Study, United States, February 14–March 27, 2022" 71 (2022) Pampati, Sanjana et al. "Ventilation Improvement Strategies Among K–12 Public Schools — the National School COVID-19 Prevention Study, United States, February 14–March 27, 2022" vol. 71, 2022 Export RIS Citation Information.

:

Pampati, Sanjana ;

Rasberry, Catherine N.

June 7, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? School-based strategies to improve ventilation are associated with reduced incidence of COVID-19 in schools. S...
Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code–level Social Vulnerability — United States, December 23, 2021–May 21, 2022

CITE Title : Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code–level Social Vulnerability — United States, December 23, 2021–May 21, 2022 Personal Author(s) : Gold, Jeremy A. W.;Kelleher, James;Magid, Jake;Jackson, Brendan R.;Pennini, Meghan E.;Kushner, Diana;Weston, Emily J.;Rasulnia, Bobby;Kuwabara, Sachiko;Bennett, Kelly;Mahon, Barbara E.;Patel, Anita;Auerbach, John; Corporate Authors(s) : CDC COVID-19 Emergency Response Team.;Palantir Technologies.;United States Department of Health and Human Services. Office of the Assistant Secretary for Preparedness and Response.; Published Date : 06/21/2022 Pages in Document : 6 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2022; v. 71 Early Release URL : https://stacks.cdc.gov/view/cdc/118441 Gold, Jeremy A. W. et al. (2022). Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code–level Social Vulnerability — United States, December 23, 2021–May 21, 2022. 71 Gold, Jeremy A. W. et al. "Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code–level Social Vulnerability — United States, December 23, 2021–May 21, 2022" 71 (2022) Gold, Jeremy A. W. et al. "Dispensing of Oral Antiviral Drugs for Treatment of COVID-19 by Zip Code–level Social Vulnerability — United States, December 23, 2021–May 21, 2022" vol. 71, 2022 Export RIS Citation Information.

:

Gold, Jeremy A. W. ;

Kelleher, James

06/21/2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Lagevrio and Paxlovid are oral antiviral drugs effective at preventing hospitalization and death in patients w...
Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment — California, December 2021–May 2022

CITE Title : Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment — California, December 2021–May 2022 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service.;Kaiser Permanente Department of Research & Evaluation.;Kaiser Permanente Bernard J. Tyson School of Medicine.;CDC COVID-19 Emergency Response Team.;Harvard T.H. Chan School of Public Health. Center for Communicable Disease Dynamics. Department of Epidemiology.;University of California, Berkeley. School of Public Health.; Published Date : 06/21/2022 Pages in Document : 5 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2022; v. 71 Early Release URL : https://stacks.cdc.gov/view/cdc/118440 Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. (2022). Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment — California, December 2021–May 2022. 71 Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. "Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment — California, December 2021–May 2022" 71 (2022) Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. "Hospitalization and Emergency Department Encounters for COVID-19 After Paxlovid Treatment — California, December 2021–May 2022" vol. 71, 2022 Export RIS Citation Information.

:

Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service. ...

06/21/2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Recurrence of COVID-19 symptoms and positive SARS-CoV-2 test results have been reported after completion of Pa...
Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) MRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022

CITE Title : Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) MRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022 Personal Author(s) : Fowlkes, Ashley L.;Yoon, Sarang K.;Lutrick, Karen;Gwynn, Lisa;Burns, Joy;Grant, Lauren;Phillips, Andrew L.;Ellingson, Katherine;Ferraris, Maria V.;LeClair, Lindsay B.;Mathenge, Clare;Yoo, Young M.;Thiese, Matthew S.;Gerald, Lynn B.;Solle, Natasha Schaefer;Jeddy, Zuha;Odame-Bamfo, Leah;Mak, Josephine;Hegmann, Kurt T.;Gerald, Joe K.;Ochoa, Jezahel S.;Berry, Mark;Rose, Spencer;Lamberte, Julie Mayo;Madhivanan, Purnima;Pubillones, Felipe A.;Rai, Ramona P.;Dunnigan, Kayan;Jones, John T.;Krupp, Karl;Edwards, Laura J.;Bedrick, Edward J.;Sokol, Brian E.;Lowe, Ashley;McLeland-Wieser, Hilary;Jovel, Krystal S.;Fleary, Deanna E.;Khan, Sana M.;Poe, Brandon;Hollister, James;Lopez, Joanna;Rivers, Patrick;Beitel, Shawn;Tyner, Harmony L.;Naleway, Allison L.;Olsho, Lauren E. W.;Caban-Martinez, Alberto J.;Burgess, Jefferey L.;Thompson, Mark G.;Gaglani, Manjusha; Corporate Authors(s) : CDC COVID-19 Emergency Response Team.;Rocky Mountain Center for Occupational and Environmental Health;University of Arizona. College of Medicine.;Leonard M. Miller School of Medicine..;Abt Associates, Rockville, Maryland;University of Arizona. College of Public Health.;Baylor Scott & White Health.;St. Luke’s (Duluth, Minnesota);Center for Health Research (Kaiser-Permanente Medical Care Program. Northwest Region) Texas A&M University. College of Medicine.; Published Date : March 11, 2022 Pages in Document : 7 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2022; v. 71 Early Release URL : https://stacks.cdc.gov/view/cdc/115393 Fowlkes, Ashley L. et al. (2022). Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) MRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022. 71 Fowlkes, Ashley L. et al. "Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) MRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022" 71 (2022) Fowlkes, Ashley L. et al. "Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) MRNA Vaccine in Preventing SARS-CoV-2 Infection Among Children Aged 5–11 Years and Adolescents Aged 12–15 Years — PROTECT Cohort, July 2021–February 2022" vol. 71, 2022 Export RIS Citation Information.

:

Fowlkes, Ashley L. ;

Yoon, Sarang K.

March 11, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Receipt of 2 doses of Pfizer-BioNTech COVID-19 Vaccine has been shown to be effective in preventing infection ...
Effectiveness of MRNA Vaccination in Preventing COVID-19–associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022

CITE Title : Effectiveness of MRNA Vaccination in Preventing COVID-19–associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022 Personal Author(s) : Tenforde, Mark W.;Self, Wesley H.;Gaglani, Manjusha;Ginde, Adit A.;Douin, David J.;Talbot, H. Keipp;Casey, Jonathan D.;Mohr, Nicholas M.;Zepeski, Anne;McNeal, Tresa;Ghamande, Shekhar;Gibbs, Kevin W.;Files, D. Clark;Hager, David N.;Shehu, Arber;Prekker, Matthew E.;Frosch, Anne E.;Gong, Michelle N.;Mohamed, Amira;Johnson, Nicholas J.;Srinivasan, Vasisht;Steingrub, Jay S.;Peltan, Ithan D.;Brown, Samuel M.;Martin, Emily T.;Monto, Arnold S.;Khan, Akram;Hough, Catherine L.;Busse, Laurence W.;Duggal, Abhijit;Wilson, Jennifer G.;Qadir, Nida;Chang, Steven Y.;Mallow, Christopher;Rivas, Carolina;Babcock, Hilary M.;Kwon, Jennie H.;Exline, Matthew C.;Botros, Mena;Lauring, Adam S.;Shapiro, Nathan I.;Halasa, Natasha;Chappell, James D.;Grijalva, Carlos G.;Rice, Todd W.;Jones, Ian D.;Stubblefield, William B.;Baughman, Adrienne;Womack, Kelsey N.;Rhoads, Jillian P.;Lindsell, Christopher J.;Hart, Kimberly W.;Zhu, Yuwei;Adams, Katherine;Surie, Diya;McMorrow, Meredith L.;Patel, Manish M.; Corporate Authors(s) : IVY Network.;CDC COVID-19 Emergency Response Team.;Vanderbilt University Medical Center, Nashville, Tennessee.;Baylor Scott & White Health.;Texas A&M University College of Medicine.;University of Colorado School of Medicine, Aurora, Colorado;University of Iowa.;Wake Forest University Baptist Medical Center.;Johns Hopkins Hospital.;Hennepin County Medical Center.;Montefiore Medical Center and Albert Einstein College of Medicine.;University of Washington School of Medicine.;Baystate Medical Center, Springfield, Massachusetts;Intermountain Medical Center.;University of Utah.;University of Michigan School of Public Health.; Published Date : March 18, 2022 Pages in Document : 7 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2022; v. 71 Early Release URL : https://stacks.cdc.gov/view/cdc/115515 Tenforde, Mark W. et al. (2022). Effectiveness of MRNA Vaccination in Preventing COVID-19–associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022. 71 Tenforde, Mark W. et al. "Effectiveness of MRNA Vaccination in Preventing COVID-19–associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022" 71 (2022) Tenforde, Mark W. et al. "Effectiveness of MRNA Vaccination in Preventing COVID-19–associated Invasive Mechanical Ventilation and Death — United States, March 2021–January 2022" vol. 71, 2022 Export RIS Citation Information.

:

Tenforde, Mark W. ;

Self, Wesley H.

March 18, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? COVID-19 mRNA vaccines provide protection against COVID-19 hospitalization among adults. However, how well mRN...
Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021

CITE Title : Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021 Personal Author(s) : Barrett, Catherine E.;Koyama, Alain K.;Alvarez, Pablo;Chow, Wilson;Lundeen, Elizabeth A.;Perrine, Cria G.;Pavkov, Meda E.;Rolka, Deborah B.;Wiltz, Jennifer L.;Bull-Otterson, Lara;Gray, Simone;Boehmer, Tegan K.;Gundlapalli, Adi V.;Siegel, David A.;Kompaniyets, Lyudmyla;Goodman, Alyson B.;Mahon, Barbara E.;Tauxe, Robert V.;Remley, Karen;Saydah, Sharon; Corporate Authors(s) : CDC COVID-19 Emergency Response Team.;National Center for Chronic Disease Prevention and Health Promotion (U.S.)Division of Diabetes Translation.; Published Date : January 7, 2022 Pages in Document : 7 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2022; v. 71 Early Release URL : https://stacks.cdc.gov/view/cdc/113211 Barrett, Catherine E. et al. (2022). Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021. 71 Barrett, Catherine E. et al. "Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021" 71 (2022) Barrett, Catherine E. et al. "Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years — United States, March 1, 2020–June 28, 2021" vol. 71, 2022 Export RIS Citation Information.

:

Barrett, Catherine E. ;

Koyama, Alain K.

January 7, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? SARS-CoV-2 infection is associated with worsening of diabetes symptoms, and persons with diabetes are at incre...
Hospitalizations of Children Aged 5–11 Years with Laboratory-confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022

CITE Title : Hospitalizations of Children Aged 5–11 Years with Laboratory-confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022 Personal Author(s) : Rader, Benjamin;Gertz, Autumn;Iuliano, A. Danielle;Gilmer, M Matthew;Wronski, Laura;Astley, Christina M.;Sewalk, Kara;Varrelman, Tanner J.;Cohen, Jon;Parikh, Rishika;Reese, Heather E.;Reed, Carrie;Brownstein, John S.; Corporate Authors(s) : COVID-NET Surveillance Team.;CDC COVID-19 Emergency Response Team.;Centers for Disease Control and Prevention (U.S.)Epidemic Intelligence Service.;General Dynamics Information Technology.;California Emerging Infections Program.;Centers for Disease Control and Prevention (U.S.)Career Epidemiology Field Officer Program.;Colorado. Department of Public Health and Environment.;Yale University. School of Public Health. Connecticut Emerging Infections Program.;Emory University School of Medicine.;Georgia Emerging Infections Program.;Veterans Affairs Medical Center (Atlanta, Ga.).;Iowa. Department of Health.;Michigan. Department of Health and Human Services.;Minnesota. Department of Health.;New Mexico Department of Health.;New York (State). Department of Health.;University of Rochester School of Medicine and Dentistry.;University of Rochester Medical Center. Rochester Emerging Infections Program.;Ohio. Department of Health.;Oregon Health Authority. Public Health Division.;Vanderbilt University Medical Center.;Salt Lake County (Utah). Health Department.; Published Date : April 19, 2022 Pages in Document : 8 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2022; v. 71 Early Release URL : https://stacks.cdc.gov/view/cdc/116443 Rader, Benjamin et al. (2022). Hospitalizations of Children Aged 5–11 Years with Laboratory-confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022. 71 Rader, Benjamin et al. "Hospitalizations of Children Aged 5–11 Years with Laboratory-confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022" 71 (2022) Rader, Benjamin et al. "Hospitalizations of Children Aged 5–11 Years with Laboratory-confirmed COVID-19 — COVID-NET, 14 States, March 2020–February 2022" vol. 71, 2022 Export RIS Citation Information.

:

Rader, Benjamin ;

Gertz, Autumn

April 19, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? COVID-19 can cause severe illness in children. Children aged 5–11 years became eligible for COVID-19 vaccina...
Post–COVID Conditions Among Adult Covid-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021

CITE Title : Post–COVID Conditions Among Adult Covid-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021 Personal Author(s) : Bull-Otterson, Lara;Baca, Sarah;Saydah, Sharon;Boehmer, Tegan K.;Adjei, Stacey;Gray, Simone;Harris, Aaron M.; Corporate Authors(s) : CDC COVID-19 Emergency Response Team.;GAP Solutions, Inc.; Published Date : May 24, 2022 Pages in Document : 5 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2022; v. 71 Early Release URL : https://stacks.cdc.gov/view/cdc/117686 Bull-Otterson, Lara et al. (2022). Post–COVID Conditions Among Adult Covid-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021. 71 Bull-Otterson, Lara et al. "Post–COVID Conditions Among Adult Covid-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021" 71 (2022) Bull-Otterson, Lara et al. "Post–COVID Conditions Among Adult Covid-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021" vol. 71, 2022 Export RIS Citation Information.

:

Bull-Otterson, Lara ;

Baca, Sarah

May 24, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? As more persons are exposed to and infected by SARS-CoV-2, reports of patients who experience persistent sympt...
Effectiveness of 2, 3, and 4 COVID-19 MRNA Vaccine Doses Among Immunocompetent Adults During Periods When SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States

CITE Title : Effectiveness of 2, 3, and 4 COVID-19 MRNA Vaccine Doses Among Immunocompetent Adults During Periods When SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States Personal Author(s) : Link-Gelles, Ruth;Levy, Matthew E.;Gaglani, Manjusha;Irving, Stephanie A.;Stockwell, Melissa;Dascomb, Kristin;DeSilva, Malini B.;Reese, Sarah E.;Liao, I-Chia;Ong, Toan C.;Grannis, Shaun J.;McEvoy, Charlene;Patel, Palak;Klein, Nicola P.;Hartmann, Emily;Stenehjem, Edward;Natarajan, Karthik;Naleway, Allison L.;Murthy, Kempapura;Rao, Suchitra;Dixon, Brian E.;Kharbanda, Anupam B.;Akinseye, Akintunde;Dickerson, Monica;Lewis, Ned;Grisel, Nancy;Han, Jungmi;Barron, Michelle A.;Fadel, William F.;Dunne, Margaret M.;Goddard, Kristin;Arndorfer, Julie;Konatham, Deepika;Valvi, Nimish R.;Currey, J. C.;Fireman, Bruce;Raiyani, Chandni;Zerbo, Ousseny;Sloan-Aagard, Chantel;Ball, Sarah W.;Thompson, Mark G.;Tenforde, Mark W.; Corporate Authors(s) : CDC COVID-19 Emergency Response Team.;Westat, Rockville, Maryland.;Texas A&M University College of Medicine. Baylor Scott & White Health.;Center for Health Research (Kaiser-Permanente Medical Care Program. Northwest Region);Columbia University Vagelos College of Physicians and Surgeons. Division of Child and Adolescent Health. Department of Pediatrics.;Columbia University Mailman School of Public Health. Department of Population and Family Health.;New York Presbyterian Hospital.;Intermountain Healthcare (Utah). Division of Infectious Diseases and Clinical Epidemiology.;HealthPartners Institute.;University of Colorado Anschutz Medical Campus. School of Medicine.;Regenstrief Institute for Health Care‏. Center for Biomedical Informatics.;Kaiser Permanente Vaccine Study Center.;Paso Del Norte Health Information Exchange (El Paso, Texas);Columbia University. Department of Biomedical Informatics.;Indiana University. Fairbanks School of Public Health;Children’s Minnesota (Minneapolis, Minnesota;Brigham Young University. Department of Public Health.;VISION Network.; Published Date : July 15, 2022 Pages in Document : 9 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2022; v. 71 Early Release URL : https://stacks.cdc.gov/view/cdc/119433 Link-Gelles, Ruth et al. (2022). Effectiveness of 2, 3, and 4 COVID-19 MRNA Vaccine Doses Among Immunocompetent Adults During Periods When SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States. 71 Link-Gelles, Ruth et al. "Effectiveness of 2, 3, and 4 COVID-19 MRNA Vaccine Doses Among Immunocompetent Adults During Periods When SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States" 71 (2022) Link-Gelles, Ruth et al. "Effectiveness of 2, 3, and 4 COVID-19 MRNA Vaccine Doses Among Immunocompetent Adults During Periods When SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated — VISION Network, 10 States" vol. 71, 2022 Export RIS Citation Information.

:

Link-Gelles, Ruth ;

Levy, Matthew E.

July 15, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? Little is known about COVID-19 vaccine effectiveness (VE) during the Omicron variant BA.2/BA.2.12.2–predomin...
Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems — United States, August 2022

CITE Title : Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems — United States, August 2022 Personal Author(s) : Massetti, Greta M.;Jackson, Brendan R.;Brooks, John T.;Perrine, Cria G.;Reott, Erica;Hall, Aron J.;Lubar, Debra;Williams, Ian T.;Ritchey, Matthew D.;Patel, Pragna;Liburd, Leandris C.;Mahon, Barbara E.; Corporate Authors(s) : CDC COVID-19 Emergency Response Team. Published Date : August 11, 2022 Pages in Document : 9 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR: Morbidity and Mortality Weekly Report 2022; v. 71 Early Release DOI : http://dx.doi.org/10.15585/mmwr.mm7133e1 Massetti, Greta M. et al. (2022). Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems — United States, August 2022. 71http://dx.doi.org/10.15585/mmwr.mm7133e1 Massetti, Greta M. et al. "Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems — United States, August 2022" 71 (2022), http://dx.doi.org/10.15585/mmwr.mm7133e1 Massetti, Greta M. et al. "Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems — United States, August 2022" vol. 71, 2022, http://dx.doi.org/10.15585/mmwr.mm7133e1 Export RIS Citation Information.

:

Massetti, Greta M. ;

Jackson, Brendan R.

August 11, 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

What is already known about this topic? High levels of immunity and availability of effective COVID-19 prevention and management tools have reduced th...
Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021

CITE Title : Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021 Personal Author(s) : Bull-Otterson, Lara;Baca, Sarah;Saydah, Sharon;Boehmer, Tegan K.;Adjei, Stacey;Gray, Simone;Harris, Aaron M.; Corporate Authors(s) : CDC COVID-19 Emergency Response Team.;GAP Solutions, Inc.; Published Date : 5 27 2022 Pages in Document : 5 pdf pages Series : Weekly Report: Morbidity and Mortality Weekly Report (MMWR) Source : MMWR Morbidity Mortal Weekly Rep. 71(21):713-717 DOI : http://dx.doi.org/10.15585/mmwr.mm7121e1 Journal Title : Morbidity and Mortality Weekly Report (MMWR) Bull-Otterson, Lara et al. (2022). Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021. 71(21). http://dx.doi.org/10.15585/mmwr.mm7121e1 Bull-Otterson, Lara et al. "Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021" 71, no. 21 (2022), http://dx.doi.org/10.15585/mmwr.mm7121e1 Bull-Otterson, Lara et al. "Post–COVID Conditions Among Adult COVID-19 Survivors Aged 18–64 and ≥65 Years — United States, March 2020–November 2021" vol. 71, no. 21, 2022, http://dx.doi.org/10.15585/mmwr.mm7121e1 Export RIS Citation Information.

:

Bull-Otterson, Lara ;

Baca, Sarah

5 27 2022 | Weekly Report: Morbidity and Mortality Weekly Report (MMWR)

:

On May 24, 2022, this report was posted as an MMWR Early Release on the MMWR website (https://www.cdc.gov/mmwr).A growing number of persons previously...